Skip to main content
logo
Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
8.50
-0.09 (-1.02%)
At close: Mar 11, 2026, 4:00 PM EDT
8.49
-0.01 (-0.12%)
After-hours: Mar 11, 2026, 4:00 PM EDT

Quoin Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-13.77-8.96-8.69-9.38-21.46-2.1
Depreciation & Amortization
0.10.10.10.10.10.1
Other Amortization
----0.28-
Asset Writedown & Restructuring Costs
--0.02---
Loss (Gain) From Sale of Investments
-0.2-0.25-0.49-0.09--
Stock-Based Compensation
1.191.261.090.76--
Other Operating Activities
---0.2214.730.38
Change in Accounts Payable
1.970.280.05-0.221.350.23
Change in Other Net Operating Assets
-0.03-0.280.040.12-0.720.05
Operating Cash Flow
-10.74-7.86-7.86-8.48-5.72-1.34
Investment in Securities
3.81-1.892.19-9.9--
Other Investing Activities
----0.25-0.63-0.13
Investing Cash Flow
3.81-1.892.19-10.15-0.63-0.13
Short-Term Debt Issued
----3.481.98
Long-Term Debt Issued
----0.14-
Total Debt Issued
----3.611.98
Short-Term Debt Repaid
----0.31--0.05
Long-Term Debt Repaid
--0.6-0.6-0.6-0.3-
Total Debt Repaid
-0.6-0.6-0.6-0.91-0.3-0.05
Net Debt Issued (Repaid)
-0.6-0.6-0.6-0.913.311.93
Issuance of Common Stock
6.2411.575.8514.8810.1-
Other Financing Activities
---0.030.040.09-0.14
Financing Cash Flow
5.6410.975.2214.0113.51.79
Net Cash Flow
-1.291.22-0.46-4.627.160.32
Cash Interest Paid
----0.39-
Levered Free Cash Flow
-5.69-4.28-4.68-6.21-7.63-
Unlevered Free Cash Flow
-5.69-4.28-4.68-5.77-7.06-
Change in Working Capital
1.94-00.1-0.090.630.27
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q